Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Khan S 

PROVIDER: S-EPMC11284769 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature